Pfizer plans to ask for approval to administer its COVID-19 vaccine to children ages 2 to 11.
Pfizer plans to ask for approval to administer its COVID-19 vaccine to children ages 2 to 11.
Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a..
U.S. states are set to begin using the vaccine from Pfizer and BioNTech to inoculate young adolescents against COVID-19 after..